ABSTRACT
STABLE PHARMACEUTICAL COMPOSITION OF CARBETOCIN
The present invention provides a stable pharmaceutical compositions of Carbetocin. The present invention also provides a stable pharmaceutical composition of Carbetocin comprising, a therapeutically effective amount of Carbetocin, auxiliary agent, an iso...
ABSTRACT
“A room temperature stable aqueous solution for injection of Clevidipine”
The present invention provides a room temperature stable aqueous solution for injection comprising Clevidipine and solubilizer selected from Vitamin E polyethylene glycol succinate, propylene glycol, polyethylene glycol, or a mi...
A solid oral pharmaceutical composition comprising Rivaroxaban or a pharmaceutically acceptable salt or solvate thereof, one or more diluent, one or more binding agent, disintegrant and other pharmaceutically acceptable excipients wherein the composition is free of wetting agent. A process of preparing a solid oral ...
ABSTRACT
AN INTRAVENOUS INFUSION OF MAGNESIUM SULPHATE
The present invention is an intravenous infusion of magnesium sulphate. The present invention also an intravenous infusion of magnesium sulphate comprising magnesium sulphate, atleast two pH adjusting agents and a suitable vehicle. The present invention al...
“A room temperature stable solution for injection of Abaloparatide”
The present invention provides a room temperature stable solution for injection comprising Abaloparatide and stabilizer selected from L – methionine, disodium EDTA, D-?-tocopheryl polyethylene glycol succinate, hydroxypropyl betadex, mannitol, S-...
The present invention provides a stable topical composition comprising Tofacitinib or a pharmaceutically acceptable salt thereof, wherein the topical composition is lotion or gel, wherein the topical composition is stable for at least 6 months when stored at 30 °C temperature and 75% relative humidity. Further, th...
“A room temperature stable solution for injection of Abaloparatide”
The present invention provides a room temperature stable solution for injection comprising Abaloparatide and stabilizer selected from L – methionine, disodium EDTA, D-?-tocopheryl polyethylene glycol succinate, hydroxypropyl betadex, mannitol, S-...
[Class : 5] Medicinal And Pharmaceutical Preparations In Class 05
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Medicinal And Pharmaceutical Preparations In Class 05
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Medicinal And Pharmaceutical Preparations In Class 05
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
View +140 more Brands for Precise Bio Pharma Private Limited.
Charges
2 Crore
20 June 2019
Axis Bank Limited
2 Crore
02 August 2011
Corporation Bank
2 Crore
30 June 2012
Ing Vysya Bank Limited
2 Crore
28 June 2021
Hdfc Bank Limited
8 Lak
31 March 2021
Hdfc Bank Limited
28 Lak
05 October 2023
Others
0
31 March 2022
Axis Bank Limited
0
31 March 2021
Hdfc Bank Limited
0
20 June 2019
Axis Bank Limited
0
28 June 2021
Hdfc Bank Limited
0
02 August 2011
Others
0
30 June 2012
Ing Vysya Bank Limited
0
05 October 2023
Others
0
31 March 2022
Axis Bank Limited
0
31 March 2021
Hdfc Bank Limited
0
20 June 2019
Axis Bank Limited
0
28 June 2021
Hdfc Bank Limited
0
02 August 2011
Others
0
30 June 2012
Ing Vysya Bank Limited
0
05 October 2023
Others
0
31 March 2022
Axis Bank Limited
0
31 March 2021
Hdfc Bank Limited
0
20 June 2019
Axis Bank Limited
0
28 June 2021
Hdfc Bank Limited
0
02 August 2011
Others
0
30 June 2012
Ing Vysya Bank Limited
0
Documents
Form PAS-3-15122020_signed
Form SH-7-14122020-signed
Copy of contract where shares have been allotted for consideration other than cash or attachment wherein the details of contract reduced in writing by the company , if any;-14122020
Valuation Report from the valuer, if any;-14122020
Copy of Board or Shareholders? resolution-14122020
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-14122020
Optional Attachment-(1)-09122020
Altered memorandum of assciation;-09122020
Copy of the resolution for alteration of capital;-09122020
Form MGT-14-02122020-signed
Altered memorandum of assciation;-12112020
Altered articles of association-12112020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-12112020
Copy of the resolution for alteration of capital;-12112020
Optional Attachment-(2)-12112020
Form DPT-3-11112020-signed
Form INC-28-05112020-signed
Form MSME FORM I-30102020_signed
Copy of court order or NCLT or CLB or order by any other competent authority.-29092020
Optional Attachment-(1)-23092020
Form CHG-4-30082020_signed
Letter of the charge holder stating that the amount has been satisfied-29082020
Form MSME FORM I-20082020_signed
Form DPT-3-01052020-signed
Instrument(s) of creation or modification of charge;-01012020
Form CHG-1-01012020_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20200101
List of share holders, debenture holders;-12112019